Actively Recruiting
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Led by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Updated on 2025-03-11
180
Participants Needed
6
Research Sites
88 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate the effect and safety of 608 in patients with nr-axSpA.
CONDITIONS
Official Title
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female and male patients at least 18 years of age at the time of screening
- Diagnosis of axial spondyloarthritis according to Ankylosing Spondylo Arthritis International Society (ASAS) axial spondyloarthritis criteria
- Objective signs of inflammation (magnetic resonance imaging or abnormal C-reactive protein)
- Total back pain as measured by numeric rating scale 4 or higher at baseline
You will not qualify if you...
- Patients with other uncontrolled active inflammatory diseases
- Clinical laboratory tests and other tests that reveal abnormalities with clinical significance
- Patients who have active Hepatitis B, Hepatitis C or HIV infections as determined by positive results at Screening
- History of cancer
- Known or suspected history of immunosuppression
- Known allergy or intolerance to mometasone furoate spray or 608/placebo
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Site 01
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
2
Site 03
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
3
Site 05
Chongqing, Chongqing Municipality, China, 400010
Actively Recruiting
4
Site 02
Zhengzhou, Henan, China, 450052
Actively Recruiting
5
Site 04
Nanjing, Jiangsu, China, 210008
Actively Recruiting
6
Site 06
Shenzhen, Shenzhen, China, 518020
Not Yet Recruiting
Research Team
Q
Qinghong Zhou, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here